WeVote
Log In

Bill

HS

Bill

A 4980

Establishes and requires coverage for routine opt-out HIV testing during provision of medical care in certain settings.

2026-2027 Regular Session Introduced by Heather Simmons

Seeks to standardize HIV testing in designated care settings with opt-out consent, ensuring insurers cover the test and linking positives to care.

Introduced, Referred to Assembly Health Committee
0
WeVote Research Nonpartisan
Bill Summary · A 4980

Summary of New Jersey Bill A-4980 (Session 222)

Title

Establishes and requires coverage for routine opt-out HIV testing during provision of medical care in certain settings.

Purpose and Intent

  • To expand routine HIV testing by integrating it into standard medical care in specified health care settings.
  • To increase early detection of HIV and link individuals to timely treatment and prevention services.
  • To implement an opt-out testing approach, normalizing HIV testing as part of routine care while preserving patient consent.

Key Provisions

  1. Routine Opt-Out HIV Testing Requirement

    • Healthcare providers would offer HIV testing as a standard component of medical care in designated settings.
    • Patients would be tested unless they explicitly decline (opt-out).

  2. Settings Affected

    • The bill targets specific medical care environments defined within the statute. (Exact settings would be listed in the bill’s text; examples typically include primary care, emergency departments, inpatient facilities, and community health centers.)

  3. Coverage and Cost

    • Insurers (public and private) would be required to cover routine HIV testing conducted under the bill without unnecessary out-of-pocket costs to patients.
    • The measure aims to remove financial barriers to HIV testing as part of routine care.

  4. Consent and Counseling

    • Procedures would specify how consent is obtained for opt-out testing.
    • Counseling requirements (pre- or post-test counseling) would be outlined, including how results are communicated to patients.

  5. Reporting and Confidentiality

    • Mechanisms for reporting aggregate testing data (for public health surveillance and program evaluation) while protecting patient confidentiality.
    • Data handling standards to ensure privacy and comply with existing health information privacy laws.

  6. Follow-Up and Linkage to Care

    • Protocols to ensure individuals who test positive are promptly connected to HIV care, treatment, and prevention services.
    • referrals to case management, support services, and state HIV programs may be specified.

  7. Effective Date and Implementation

    • Timeline for when the routine opt-out testing requirement would take effect.
    • Any phased implementation or regulatory guidance required to operationalize the provision in healthcare settings.

Who Would Be Affected

  • Patients: Individuals receiving medical care in targeted settings would be offered an HIV test as part of routine care, with the option to decline.
  • Healthcare Providers: Medical professionals and facilities in the defined settings would administer testing and follow the consent, counseling, and referral procedures.
  • Insurers: Public and private insurers would cover the testing costs as part of standard care.
  • Public Health Entities: State health departments would collect de-identified data to monitor testing uptake and HIV trends.

Procedural and Timeline Considerations

  • The bill outlines the steps for implementing routine opt-out testing, including consent processes, financial coverage, and linkage-to-care protocols.
  • It specifies the timeframe for compliance by providers and insurers, and any required regulatory or administrative updates to existing health statutes.

Potential Impacts

  • Public Health: Increased HIV testing rates, earlier diagnosis, and improved linkage to treatment and prevention services.
  • Cost Implications: Potential short-term increases in testing costs covered by insurers, offset by long-term savings from reduced HIV transmission and expanded treatment access.
  • Patient Experience: Testing becomes a standard, less stigmatized part of care, with autonomy preserved through opt-out ability.

Note: Specific statutory language (e.g., exact settings covered, consent method details, and reporting requirements) would be found in the bill text. This summary conveys the bill’s core aims and anticipated effects based on its title and description.

Compiled from official sources — confirm details with the bill’s official record.

Sign in to ask a question.